The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...